Isotretinoin therapy for acne: results of a multicenter dose-response study - PubMed (original) (raw)
Clinical Trial
Isotretinoin therapy for acne: results of a multicenter dose-response study
J S Strauss et al. J Am Acad Dermatol. 1984 Mar.
Abstract
One hundred fifty patients with treatment-resistant nodulocystic acne were entered into a double-blind clinical study. Three different dosing levels (0.1, 0.5, 1.0 mg/kg/day) were used in equal-sized groups. In addition to the clinical response, the clinical side effects, the laboratory abnormalities, and the duration of the induced remissions were evaluated with each dose of the drug. There was a highly significant clinical response to treatment with all three dosages of isotretinoin. There was no significant difference in the clinical response between dosages. However, 42% of the patients who received 0.1 mg/kg/day of isotretinoin required retreatment with the drug. This finding, coupled with only minor differences in the clinical side effects and the laboratory abnormalities, indicates that higher dose levels of isotretinoin are indicated for treatment of nodulocystic acne.
Similar articles
- A dose-response study of I3-cis-retinoic acid in acne vulgaris.
Jones DH, King K, Miller AJ, Cunliffe WJ. Jones DH, et al. Br J Dermatol. 1983 Mar;108(3):333-43. doi: 10.1111/j.1365-2133.1983.tb03973.x. Br J Dermatol. 1983. PMID: 6219690 Clinical Trial. - Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion.
Goldstein JA, Socha-Szott A, Thomsen RJ, Pochi PE, Shalita AR, Strauss JS. Goldstein JA, et al. J Am Acad Dermatol. 1982 Apr;6(4 Pt 2 Suppl):760-5. doi: 10.1016/s0190-9622(82)70066-0. J Am Acad Dermatol. 1982. PMID: 6461679 Clinical Trial. - Isotretinoin and tetracycline in the management of severe nodulocystic acne.
Lester RS, Schachter GD, Light MJ. Lester RS, et al. Int J Dermatol. 1985 May;24(4):252-7. doi: 10.1111/j.1365-4362.1985.tb05775.x. Int J Dermatol. 1985. PMID: 3159698 Clinical Trial. - Isotretinoin treatment of acne and related disorders: an update.
Shalita AR, Cunningham WJ, Leyden JJ, Pochi PE, Strauss JS. Shalita AR, et al. J Am Acad Dermatol. 1983 Oct;9(4):629-38. doi: 10.1016/s0190-9622(83)70176-3. J Am Acad Dermatol. 1983. PMID: 6226726 Review. - Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.
Ward A, Brogden RN, Heel RC, Speight TM, Avery GS. Ward A, et al. Drugs. 1984 Jul;28(1):6-37. doi: 10.2165/00003495-198428010-00002. Drugs. 1984. PMID: 6235105 Review.
Cited by
- Rationale for Use of Micronized Isotretinoin for Treatment of Acne Vulgaris: Practical Considerations and Therapeutic Advantages.
Del Rosso JQ. Del Rosso JQ. J Clin Aesthet Dermatol. 2023 Sep;16(9):20-24. J Clin Aesthet Dermatol. 2023. PMID: 37720199 Free PMC article. Review. - Oral Isotretinoin and Its Uses in Dermatology: A Review.
Paichitrojjana A, Paichitrojjana A. Paichitrojjana A, et al. Drug Des Devel Ther. 2023 Aug 25;17:2573-2591. doi: 10.2147/DDDT.S427530. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37649956 Free PMC article. Review. - Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management.
Daniele SG, Kim SR, Grada A, Moore AY, Suozzi KC, Bunick CG. Daniele SG, et al. Am J Clin Dermatol. 2023 Mar;24(2):199-223. doi: 10.1007/s40257-022-00746-4. Epub 2022 Dec 20. Am J Clin Dermatol. 2023. PMID: 36539678 Review. - Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis.
Kapała J, Lewandowska J, Placek W, Owczarczyk-Saczonek A. Kapała J, et al. Int J Environ Res Public Health. 2022 May 26;19(11):6463. doi: 10.3390/ijerph19116463. Int J Environ Res Public Health. 2022. PMID: 35682048 Free PMC article. Review. - Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review.
Lytvyn Y, McDonald K, Mufti A, Beecker J. Lytvyn Y, et al. JAAD Int. 2022 Feb 10;6:125-142. doi: 10.1016/j.jdin.2022.01.002. eCollection 2022 Mar. JAAD Int. 2022. PMID: 35199047 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical